シンガポールの高齢者のさまざまなタンパク質飲料の消費後の代謝物の変化
The study aims to investigate the acute effects of different protein sources (i.e., casein, whey, soy) on metabolomic profiles (e.g., amino acids in the blood), along with other outcomes such as cognitive function, mood, and appetite. While the study does not directly aim to prevent, prognosticate, diagnose, or alleviate any disease, it may provide insights that could inform dietary recommendations and support disease prevention efforts in older adults.
調査の概要
状態
詳細な説明
This study will be a double-blind, randomised, placebo-controlled trial using a crossover study design. 25 older adults (aged 60 to 80) will be recruited and assigned to consume 4 different test drinks in a random order on 4 different visits. This study aims to investigate whether higher protein consumption of different sources will influence postprandial plasma and urinary metabolomic profiles, cognition, mood and appetite. The study will comprise 1 screening visit and 4 test visits separated separated by a minimum washout period of >7 days
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Singapore、シンガポール、117550
- NUS, Department of Food Science and Technology, 1 Science Drive 3, Block S13, #03-07
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- English-literate and able to give informed consent
- Adults 60 to 80 years old (inclusive)
- (If applicable) Postmenopausal
- BMI of 18·5 to 30 kg/m2 (inclusive)
Exclusion Criteria:
-
Currently participating in another clinical study that involves altering the regular diet and/or involves consuming a dietary supplement or investigated food product as an intervention
-
Weight change >3 kg in the past 3 months
-
Exercising vigorously over the past 3 months (i.e., engaging in high-intensity exercises for more than 3 hours a week, where high-intensity exercises leave one out of breath and unable to talk or sing during the workout)
-
Current smokers or have quit smoking for less than 5 years
-
Drinking >2 alcoholic drinks per day (i.e., one drink is defined as either 150 ml of wine, 340 ml of beer/cider or 45 ml of distilled spirit)
-
If drinking ≤2 alcoholic drinks per day, not willing to stop consumption of alcoholic beverages two days before and on the day of the test visits (total 12 days)
-
Not willing to stop consumption of caffeinated beverages 10 to 12 hours before and on the day of the test visits (total 4 days)
-
Taking supplements containing omega-3, magnesium, gamma-aminobutyric acid (GABA), L-theanine, melatonin and/or 5-hydroxytryptophan for the past 3 months, and not willing to discontinue usage 3 months before and during the study duration
-
Currently on a specialised diet (e.g., vegetarian, vegan, weight loss diet)
- Had serious food allergies in the past, or having intolerance, sensitivities or allergies to any of the following: milk/dairy products (e.g., casein, whey), starch/starch-derived products (e.g., rice, corn, wheat, potato), soy/soy-derived products, gluten, eggs, nuts, peanuts, fish and crustaceans.
-
Disease or impairment of the kidney and/or liver
-
Currently diagnosed with diabetes, sleep disorders, gastrointestinal issues (e.g., lactose intolerance, irritable bowel syndrome), gout and/or G6PD deficiency
-
History of diseases known to affect the central nervous system (e.g., heart disease, stroke, migraine headaches, multiple sclerosis, Parkinson's disease, mental illnesses)
-
Taking antibiotics 2 weeks prior to study participation
-
Taking medication known to interfere with cognitive function and mental wellbeing (e.g., benzodiazepines, antidepressants, other central nervous agents)
-
Taking anti-hypertensive or cholesterol-lowering drugs for less than 3 years unless medically declared by an official doctor to be in stable condition
-
Poor peripheral venous access based on past experiences with blood drawing
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Casein Protein Drink
30 g protein equivalent of casein protein isolate dissolved in ~250 mL of water |
30 g protein equivalent of casein protein isolate dissolved in ~250 mL of water |
|
実験的:Whey Protein Drink
30 g protein equivalent of whey protein isolate dissolved in ~250 mL of water |
30 g protein equivalent of whey protein isolate dissolved in ~250 mL of water |
|
実験的:Soy Protein Drink
30 g protein equivalent of soy protein isolate dissolved in ~250 mL of water |
30 g protein equivalent of soy protein isolate dissolved in ~250 mL of water |
|
プラセボコンパレーター:Maltodextrin Drink
30 g carbohydrate equivalent of maltodextrin powder dissolved in ~250 mL of water |
30 g carbohydrate equivalent of maltodextrin powder dissolved in ~250 mL of water |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in metabolites found in plasma (plasma metabolomics)
時間枠:Baseline, 15, 30, 60, 90, 120, 180, 240, 300 minutes
|
Untargeted metabolomics profiling of plasma will be conducted using ultra performance liquid chromatography-quadrupole time of flight-mass spectrometry (UPLC-QTOF-MS) |
Baseline, 15, 30, 60, 90, 120, 180, 240, 300 minutes
|
|
Changes in metabolites found in urine (urinary metabolomics)
時間枠:Baseline, 60, 120, 180, 240, 300 minutes
|
Untargeted metabolomics profiling of urine will be conducted using ultra performance liquid chromatography-quadrupole time of flight-mass spectrometry (UPLC-QTOF-MS) |
Baseline, 60, 120, 180, 240, 300 minutes
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Cognitive Function
時間枠:Baseline, 15, 60, 120, 180, 240, 300 minutes
|
The Computerised Mental Performance Assessment System (COMPASS) will be administered via a laptop. The COMPASS tests consist of 5 consecutive tests, including Digit Vigilance, Stroop, Rapid Visual Information Processing, Computerised Corsi Blocks Lite, Alphabetic Working Memory and Serial Subtraction, where the correctness and reaction time will be recorded. The test is expected to take around 15 minutes. |
Baseline, 15, 60, 120, 180, 240, 300 minutes
|
|
Mood
時間枠:Baseline, 15, 60, 120, 180, 240, 300 minutes
|
The Profile of Mood States (POMS) questionnaire will be administered, which contains various words that describe feelings. Participants will indicate, for each word, how they currently feel on scale of 0 (Not at all) to 4 (Extremely). |
Baseline, 15, 60, 120, 180, 240, 300 minutes
|
協力者と研究者
協力者
捜査官
- 主任研究者:Jung Eun Kim, Ph.D., R.D.、National University of Singapore, Department of Food Science and Technology
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- S31
- NUS-IRB-2025-19 (その他の識別子:National University of Singapore Institutional Review Board (NUS IRB))
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Electronic copies of the data with identifiable participant information will be kept on NUS OneDrive with access limited only Dr Kim Jung Eun and her research staff. All data will be de-identified prior to statistical analyses.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。